Study identification

EU PAS number

EUPAS1000000343

Study ID

1000000343

Official title and acronym

Patient characteristics and utilization patterns of romosozumab in routine clinical practice: a European, multi-country, non-interventional study (PRIME)

DARWIN EU® study

No

Study countries

Belgium
Germany
Greece
Italy
Spain
Sweden
Switzerland
United Kingdom

Study status

Ongoing

Contact details

Alireza Moayyeri

Primary lead investigator
Study timelines

Date when funding contract was signed

Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

UCB Biopharma SRL
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable